Clinical Trials Sponsored by Bayer

Total 2501 results

Bayer

Completed

Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections (EMERON)

Urinary Tract Infection

Italy
Bayer

Completed

Identification of Hepatic Lesions

Hepatic Neoplasms

Italy
Bayer

Completed

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (ODIXa-HIP2)

Venous Thromboembolism

Italy, Spain, Denmark, Netherlands, Belgium, Austria, Germany, Poland, Sweden, Israel, France, Norway, United Kingdom
Bayer

Completed

Efficacy and Tolerability of Angeliq in Thai Women

Postmenopause
UNICANCER
Bayer

Not yet recruiting

Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging (PEACE8)

Prostatic Cancer, Castration-Resistant
MedSIR
Bayer

Completed

Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status

Prostate Cancer

Spain
Novartis
Bayer

Completed

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.

Colorectal Neoplasms | Rectal Neoplasms | Colonic Neoplasms

Belgium, Germany, Italy, United States, Taiwan, Switzerland, Spain, Canada, Slovakia, United Kingdom, New Zealand, Australia, Portugal, Brazil, Hungary, Czechia, France, Netherlands, Sweden
Bayer
Amgen

Withdrawn

GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start

Carcinoma, Hepatocellular

United States
Bayer
Amgen

Completed

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Melanoma | Cancer

United States
Bayer
Amgen

Completed

Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer

Carcinoma, Renal Cell

United States, United Kingdom
Bayer
Novartis

Completed

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

Bronchiectasis

Spain, Germany, Australia, United States, United Kingdom, Sweden
Bayer
Shire

Completed

Study in Chronic Kidney Disease (CKD) Not on Dialysis

Hyperphosphatemia

Japan
Bayer
Novartis

Completed

Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis

Cystic Fibrosis

United States, Israel, Germany, Canada, Australia, Sweden, Denmark, Norway, United Kingdom
Bayer
GlaxoSmithKline

Completed

Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction

Erectile Dysfunction

United States, Canada
Bayer
GlaxoSmithKline

Completed

Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and Hyperlipidemia

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

Erectile Dysfunction
AstraZeneca
Bayer

Recruiting

Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA)

Metastatic Prostate Cancer

Italy, United Kingdom, Australia, United States
UNICANCER
Bayer

Recruiting

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

Prostate Cancer Metastatic

Spain, France, Ireland, Belgium
UNICANCER
Bayer

Terminated

Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas (REGIRI)

Adenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the Stomach

France
Bayer
Novartis

Completed

Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

Bronchiectasis | Pulmonary Disease, Chronic Obstructive

United States
Bayer
Novartis

Completed

Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) (RESPIRE 1)

Bronchiectasis

Spain, United States, New Zealand, Japan, France, Australia, Germany, Denmark, Israel, United Kingdom, Latvia, Italy, Slovakia, Argentina
Bayer
Novartis

Completed

Inhalation Flow Rate-study

Bronchiectasis

Germany
Bayer
Shire

Completed

Long-term Study in Chronic Kidney Disease (Extension From Study 14817)

Hyperphosphatemia

Japan
Bayer
GlaxoSmithKline

Completed

BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction

Erectile Dysfunction

Turkey
Bayer
GlaxoSmithKline

Completed

Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Study Evaluating the Efficacy and Safety of Flexible-dose Vardenafil in Subjects With Erectile Dysfunction

Erectile Dysfunction
Bayer
Amgen

Completed

A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

Melanoma

United States, Canada, Germany, France, United Kingdom, Australia, Netherlands
Bayer
Parexel

Completed

Birth Control Patch Study

Contraception

Austria, Czech Republic, Netherlands
Bayer
Amgen

Completed

Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer

Carcinoma, Renal Cell

Italy, Spain, Canada, United States, Russian Federation, France, Australia, Chile, Germany, Hungary, Israel, United Kingdom, South Africa, Poland, Netherlands, Belgium, Ukraine, Argentina, Brazil
Bayer
Amgen

Completed

BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)

Cancer | Carcinoma, Non-Small Cell Lung

United States, Germany
Bayer
GlaxoSmithKline

Completed

Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 Weeks

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

Erectile Dysfunction
Novartis
Bayer

Completed

Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer

Neoplasm Metastasis | Tumors

United States
Bayer
GlaxoSmithKline

Terminated

ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

Ovarian Cancer | Advanced Solid Tumors (Excluding Prostate Cancer)

United States
Bayer
CureVac

Withdrawn

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older (CV-NCOV-011)

Coronavirus Disease 2019 (COVID-19) | SARS-CoV-2 Infection
Bayer
Amgen

Completed

Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

Thyroid Neoplasms

France, China, Korea, Republic of, United States, Spain, Russian Federation, United Kingdom, Netherlands, Sweden, Austria, Italy, Bulgaria, Poland, Saudi Arabia, Germany, Japan, Belgium, Denmark
Bayer
Novartis

Completed

Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) (RESPIRE 2)

Bronchiectasis

China, Hong Kong, Germany, Philippines, Russian Federation, United States, Australia, Austria, Czechia, Taiwan, Brazil, Korea, Republic of, Netherlands, Thailand, Latvia, Romania, Turkey, Serbia, Portugal, Bulgaria, Slovakia, Poland, Argenti... and more
Bayer
Amgen

Completed

Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)

Carcinoma

United States
Bayer
GlaxoSmithKline

Completed

FDA Phase IV - Commitment - Retinal Function Study

Safety
Bayer
GlaxoSmithKline

Completed

Assessment of Duration of Erection With Vardenafil 10 mg

Erectile Dysfunction
Bayer
Amgen

Completed

Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction

Erectile Dysfunction

Russian Federation
Bayer
GlaxoSmithKline

Completed

Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension

Erectile Dysfunction
Bayer
Amgen

Completed

Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects

Metastatic Colorectal Cancer

Belgium, Italy, Poland, Spain, Russian Federation, United States, Hungary, Romania, United Kingdom, Ukraine
Bayer
GlaxoSmithKline

Completed

Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury

Erectile Dysfunction
Bayer
Novartis

Completed

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

Disease, Pulmonary

Germany
Bayer
Amgen

Completed

Sorafenib/Docetaxel Dose Escalation Trial

Neoplasms

United States
Novartis
Bayer

Completed

A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers

Healthy
Bayer
GlaxoSmithKline

Completed

Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse

Erectile Dysfunction

3

Subscribe